COMPARE · Reviewed August 3, 2026
CON vs OPCH
Verdict: Side-by-side breakdown using the Bull Rankings model. CON scored 71.3, OPCH scored 76.8 — OPCH leads.
Compare another set
CON
Concentra Group Holdings Parent, Inc.
71.3
$31.70 · $4.1B
fundamentals as of
Score gap
5.5
OPCH leads
OPCH
Option Care Health, Inc.
76.8
$23.70 · $3.5B
fundamentals as of
The model, pillar by pillar (0–100 each)
CON
stronger →← stronger
OPCH
73
Qualityreturns · margins · balance sheet
62
86
Growthrevenue & earnings expansion
92
58
Valuevaluation vs sector peers
79
OPCH is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
CON
OPCH
$211mC
FCF
$213mC
+15.5%B+
Rev
+16.2%B+
4.68D
D/E
1.01C
22.8xB+
P/E
18.0xA-
1.65C+
PEG
1.23B
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
CON
OPCH
25% below
Price vs fair valuelower is cheaper
33% below
~1%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-3%/yr
+19%
1-yr DCF upside
+36%
+33%
5-yr DCF upside
+49%
+58%
10-yr DCF upside
+70%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CON
Why this score
- Durable high returns
- Short track record
OPCH
Why this score
- Buying back stock
The companies
CONConcentra Group Holdings Parent, Inc.
Why now
Medical Care Facilities · market cap $4.1b. 4% off the 52-week high of $32.86. Revenue growing +15%, comfortably above the S&P median. 8 sell-side analysts publish a mean 1-yr target of $33.38 (implying +5% upside).
Moat
ROE 42% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 119% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
D/E 4.68 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer.
OPCHOption Care Health, Inc.
Why now
Medical Care Facilities · market cap $3.5b. Down 36% from 52-week high of $36.80 — deep drawdown territory. Revenue growing +16%, comfortably above the S&P median. 12 sell-side analysts rate this a Buy with a mean 1-yr target of $28.58 (implying +21% upside).
Moat
ROE 15% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 103% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 36% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Net margin 4.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.